Sopharma AD (SPH) — Capital Reinvestment Ratio
Sopharma AD (SPH) has a Capital Reinvestment Ratio of 1.72x as of December 2024, meaning it reinvests 2% of its operating cash flow (zł54.42 Million) in capital expenditures (zł93.50 Million). See how leveraged is Sopharma AD's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sopharma AD Capital Reinvestment Ratio (2011–2024)
This chart tracks Sopharma AD's Capital Reinvestment Ratio across 11 annual periods. Check SPH cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sopharma AD (2011–2024)
Year-by-year Capital Reinvestment Ratio for Sopharma AD from 2011 to 2024. For live market cap and broader valuation context, see market value of Sopharma AD.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.58x | zł76.73 Million | zł121.39 Million | ▲ +64.6% |
| 2023 | 0.96x | zł45.03 Million | zł43.29 Million | ▲ +415.9% |
| 2022 | 0.19x | zł124.62 Million | zł23.22 Million | ▼ -81.0% |
| 2018 | 0.98x | zł28.34 Million | zł27.84 Million | ▲ +74.4% |
| 2017 | 0.56x | zł40.00 Million | zł22.53 Million | ▲ +56.5% |
| 2016 | 0.36x | zł50.64 Million | zł18.23 Million | ▼ -66.0% |
| 2015 | 1.06x | zł21.31 Million | zł22.59 Million | ▼ -18.0% |
| 2014 | 1.29x | zł20.18 Million | zł26.07 Million | ▲ +2.3% |
| 2013 | 1.26x | zł29.25 Million | zł36.96 Million | ▼ -29.9% |
| 2012 | 1.80x | zł35.20 Million | zł63.43 Million | ▲ +69.0% |
| 2011 | 1.07x | zł38.40 Million | zł40.97 Million | — |